Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus

Renato Valenti, Giulia Cantini, Rossella Marcucci, Marco Marrani, Angela Migliorini, Nazario Carrabba, Vincenzo Comito, Ruben Vergara, Giampaolo Cerisano, Guido Parodi, Rosanna Abbate, Anna Maria Gori, Gian Franco Gensini, David Antoniucci

Research output: Contribution to journalArticle

Abstract

Background The study sought to determine the impact of high residual platelet reactivity (HRPR) on long-term cardiac mortality in diabetic patients treated with PCI for CTO. No data exist about the impact of HRPR after 600 mg clopidogrel loading on long-term clinical outcome in patients with diabetes mellitus and treated with percutaneous coronary angioplasty (PCI) for chronic total occlusion (CTO). Methods From the Florence CTO-PCI registry, we identified consecutive diabetic patients with available in vitro platelet reactivity assessment by light transmittance aggregometry after a loading dose of 600 mg of clopidogrel. HRPR was defined as residual platelet aggregation by 10 μmol/L ADP test ≥ 70%. The primary end point of the study was long-term cardiac mortality. Results Two-hundred and three diabetic patients underwent CTO-PCI. The incidence of HRPR was 23%. The 3-year cardiac survival was lower in the HRPR group than the low residual platelet reactivity (LRPR) group (70 ± 7% and 92 ± 3%, respectively; p = 0.001). Within the oral antidiabetic patients there were no significant differences in long-term survival between HRPR and LRPR groups. Conversely, the association of insulin therapy and HRPR was related to a dramatic decrease in survival compared to the LRPR group (34 ± 14% vs. 89 ± 4%; p <0.001). At multivariable analysis insulin therapy (HR 4.31; p = 0.001) and HRPR (HR 3.26; p = 0.004) were significantly related to long-term mortality, while completeness of revascularization was inversely related to cardiac mortality (HR 0.40; p = 0.029). Conclusion HRPR is a strong marker of increased risk of cardiac death in patients with DM who underwent PCI for CTO.

Original languageEnglish
Pages (from-to)561-567
Number of pages7
JournalInternational Journal of Cardiology
Volume201
DOIs
Publication statusPublished - Oct 10 2015

    Fingerprint

Keywords

  • Coronary occlusion
  • Diabetes mellitus
  • Platelet reactivity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Valenti, R., Cantini, G., Marcucci, R., Marrani, M., Migliorini, A., Carrabba, N., Comito, V., Vergara, R., Cerisano, G., Parodi, G., Abbate, R., Gori, A. M., Gensini, G. F., & Antoniucci, D. (2015). Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus. International Journal of Cardiology, 201, 561-567. https://doi.org/10.1016/j.ijcard.2015.04.052